<SEC-DOCUMENT>0001193125-25-261723.txt : 20251103
<SEC-HEADER>0001193125-25-261723.hdr.sgml : 20251103
<ACCEPTANCE-DATETIME>20251103080232
ACCESSION NUMBER:		0001193125-25-261723
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20251102
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251103
DATE AS OF CHANGE:		20251103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vor Biopharma Inc.
		CENTRAL INDEX KEY:			0001817229
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				811591163
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39979
		FILM NUMBER:		251442175

	BUSINESS ADDRESS:	
		STREET 1:		500 BOYLSTON STREET
		STREET 2:		SUITE 1350
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-655-6580

	MAIL ADDRESS:	
		STREET 1:		500 BOYLSTON STREET
		STREET 2:		SUITE 1350
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>vor-20251102.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-11-03T07:30:03.9692+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:vor="http://vorbiopharma.com/20251102" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_d269f412-7bbb-4e27-99ca-f6eeb2d2d31c" name="dei:AmendmentFlag" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304">false</ix:nonNumeric><ix:nonNumeric id="F_a2ae7a8b-4a73-4f15-851c-a21115fe8a20" name="dei:EntityCentralIndexKey" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304">0001817229</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="vor-20251102.xsd"/></ix:references><ix:resources><xbrli:context id="C_bb4ba679-5702-494c-8228-5e49f4a42304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-02</xbrli:startDate><xbrli:endDate>2025-11-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><h2 style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_549c51ef-d6e0-4922-8f34-449c74f5ee43" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></h2><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_8e00f74b-192a-4c8d-92b2-e3acb3f65b40" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">November 02, 2025</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3cb19f6f-2933-4b97-9852-68989e38d1d1" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VOR BIOPHARMA INC.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:18%;box-sizing:content-box;"/>
     <td style="width:41%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_42afa5b0-01a1-481d-87dd-901d341a30c1" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e4f50a0e-1df1-4052-ba53-61091314dd5e" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-39979</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_70cafe6c-ee5d-4242-b3f2-235351ec3bb2" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">81-1591163</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_cf2a30c7-21a3-479c-beae-03cb0f21b70e" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">500 Boylston Street, Suite 1350</span></ix:nonNumeric></span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_28a86103-7517-4ef6-9cee-4c2e741197b0" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Boston</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_4529cda7-c8aa-4d7c-bcf8-070f53e9938a" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Massachusetts</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d33fa4c2-7bce-4284-9dc2-952e7d060e89" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">02116</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_4ba181fc-3d9d-4d23-81c3-fd3ecb22c6cc" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">617</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_727d9962-26e0-4c19-b6ce-3c77b8648358" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">655-6580</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:3pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6f78b5f3-90cc-46bd-b828-98e581849739" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4a2e22ad-438d-49b4-a4d5-f0900fd38c43" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_13f79c29-8e15-4212-99d7-d1360d4ef519" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0301cb99-79bf-4b9b-b576-e2b176ad45c7" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:38%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:45%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_f8ddab9f-4aa8-4fe0-92c6-6bcd16928f92" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_22ca2978-aebc-405f-874a-ba29fa85e53d" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">VOR</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_339b2dcf-590f-4644-9ac5-762cb70315c7" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_28c011f0-7479-4f52-aeb4-b4e8f66e0985" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;"><ix:nonNumeric id="F_12c0cdeb-8d55-472a-8f04-58df855ddada" contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 2, 2025 (the &#8220;Effective Date&#8221;), Vor Biopharma Inc. (the &#8220;Company&#8221;) and Dr. Qing Zuraw, the Company&#8217;s Chief Development Officer, entered into an amendment (the &#8220;Employment Agreement Amendment&#8221;) to Dr. Zuraw&#8217;s employment agreement with the Company dated July 17, 2025 (the &#8220;Employment Agreement&#8221;). The Employment Agreement Amendment provides that (i) in addition to the other severance benefits set forth in the Employment Agreement, in the event Dr. Zuraw is terminated by the Company without cause, Dr. Zuraw will be entitled to a pro-rated portion of her 2025 target bonus and, if applicable, a pro-rated portion of her 2026 target bonus, payable in a lump sum, and (ii) if Dr. Zuraw resigns for any reason after December 31, 2025, she will be entitled to the same severance benefits as are payable in the event of a termination by the Company without cause. The Employment Agreement Amendment is effective for five months following the Effective Date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The foregoing summary of the Employment Agreement Amendment is not complete and is qualified in its entirety by reference to the full text of the Employment Agreement Amendment, a copy of which will be filed as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025.</span></p><h2 style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7.01 Regulation FD Disclosure.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 3, 2025, the Company issued a press release announcing the appointment of Dr. Jeremy Sokolove as Chief Medical Officer, a copy of which is furnished as Exhibit 99.1 to this report and incorporated herein by reference.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Company&#8217;s filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.</span></p><h2 style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) Exhibits</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:5.42%;box-sizing:content-box;"/>
     <td style="width:4.48%;box-sizing:content-box;"/>
     <td style="width:90.1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit<br/>&#160;No.&#8195;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    </tr>
    <tr style="height:6pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="vor-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press Release dated November 3, 2025.</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:44%;box-sizing:content-box;"/>
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:46%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Vor Biopharma Inc.</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 3, 2025</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jean-Paul Kress</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name: Jean-Paul Kress<br/>Title: Chief Executive Officer</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>vor-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2025-11-03T07:30:03.9592+00:00 --><!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><img src="img246614764_0.jpg" alt="img246614764_0.jpg" style="width:146px;height:53px;"></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">BOSTON, Mass., November 3, 2025 (GLOBE NEWSWIRE)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> &#x2014; Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Jeremy Sokolove, M.D., as Chief Medical Officer. Dr. Sokolove brings more than two decades of clinical and translational experience in rheumatology and autoimmune disease research and development to the company&#x2019;s leadership team.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;We are thrilled to welcome Jeremy to Vor Bio,&#x201d; said Jean-Paul Kress, M.D., Chief Executive Officer and Chairman of the Board. &#x201c;His deep clinical expertise as a rheumatologist, coupled with his strong track record in industry and as a thought leader in autoimmune and inflammatory disease clinical research, makes him a perfect fit to drive our clinical strategy. With Jeremy on board, we are more confident than ever in advancing our dual BAFF/APRIL approach toward meaningful impact for patients.&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Most recently, Dr. Sokolove served as Chief Medical Officer In-Residence at Roivant Sciences where he led strategic assessment and in-licensing of novel therapeutic opportunities while providing operational leadership, clinical guidance, and translational expertise across Roivant&#x2019;s emerging and established portfolio companies.  Before that, he was Chief Medical Officer at Odyssey Therapeutics, leading the transition of the company to a clinical-stage biotechnology organization focused on next-generation immunomodulators for autoimmune and inflammatory diseases. Earlier, Dr. Sokolove was Senior Vice President and Head of Clinical Pharmacology and Experimental Medicine at GSK, where he led early and translational development across the specialty pharma portfolio, and previously Head of Immunology Translational Science at AbbVie, directing early-phase clinical programs and building portfolio-wide translational medicine strategy. He began his career on the faculty at Stanford University School of Medicine as a practicing rheumatologist and primary investigator, where his research focused on biomarker discovery and immune-mediated disease mechanisms.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Dr. Sokolove has practiced extensively as an internist and rheumatologist, treating patients and leading clinical research programs focused on autoimmune and inflammatory disorders. He has published extensively in the fields of immunology and rheumatology, contributing to the understanding of immune-mediated disease mechanisms. His academic credentials include board certification in internal medicine and rheumatology, and he holds an MD from the Boston&#x202f;University&#x202f;School&#x202f;of&#x202f;Medicine.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;I am joining Vor Bio because I see strong scientific and clinical potential in the BAFF/APRIL pathways to precisely modulate the core mechanisms underlying autoimmune diseases,&#x201d; said Dr. Sokolove.  &#x201c;Telitacicept represents a differentiated, near-term opportunity to meaningfully improve outcomes for patients with limited therapeutic options or those who depend on broad immunosuppression. I look forward to working with the team to execute a global clinical development program for Telitacicept that could translate into a therapy that can make a real difference in the lives of patients.&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">About Vor Bio</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><img src="img246614764_0.jpg" alt="img246614764_0.jpg" style="width:146px;height:53px;"></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">www.vorbio.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words &#x201c;aim,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;can,&#x201d; &#x201c;continue,&#x201d; &#x201c;could,&#x201d; &#x201c;design,&#x201d; &#x201c;enable,&#x201d; &#x201c;expect,&#x201d; &#x201c;initiate,&#x201d; &#x201c;intend,&#x201d; &#x201c;may,&#x201d; &#x201c;on-track,&#x201d; &#x201c;ongoing,&#x201d; &#x201c;plan,&#x201d; &#x201c;potential,&#x201d; &#x201c;should,&#x201d; &#x201c;target,&#x201d; &#x201c;update,&#x201d; &#x201c;will,&#x201d; &#x201c;would,&#x201d; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements in this press release include Vor Bio&#x2019;s statements regarding the potential benefits of telitacicept and the dual BAFF/APRIL approach, including the potential of the BAFF/APRIL pathways to precisely modulate the core mechanisms underlying autoimmune diseases, and telitacicept&#x2019;s potential to meaningfully improve outcomes for patients with limited therapeutic options or those who depend on broad immunosuppression</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"> and to </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">make a real difference in the lives of patients.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Vor Bio may not actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements as a result of various factors, including the data for our product candidates may not be sufficient for obtaining regulatory approval to commercialize products; we may not be able to execute our business plans, including meeting our planned clinical and regulatory milestones and timelines, and possible limitations of financial and other resources. These and other risks are described in greater detail under the caption &#x201c;Risk Factors&#x201d; included in Vor Bio&#x2019;s most recent annual or quarterly report and in other reports it has filed or may file with the Securities and Exchange Commission.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Any forward-looking statements contained in this press release speak only as of the date hereof, and Vor Bio expressly disclaims any obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as may be required by law.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Media &amp; Investor Contacts:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"><br>Carl Mauch</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">cmauch@vorbio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Sarah Spencer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">investors@vorbio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img246614764_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img246614764_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (O!@P# 2(  A$! Q$!_\0
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M45#X9X;:M_J_DFO;*L"G]ZH)KY,/9T_^?</_  &/^1^H'_#XC]O/_HIWAO\
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M)^$W_P ^ZC_B(I_8G_Z)?^U+_P"$3\)O_GW5_&-11_Q!W@O_ )\9C_X7U/\
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M_:0\6Z7]G\>?M!>3_P (S]JAVW>C_"/1;F3^Q?*WCS(/^$UUE+GQ)/L)AO\
M1+/P?=+\R&OCN.>!.">%.'L5F,*.->.JN.$RVG4Q]249XRLFXSE'E7-##TX5
M,1-:*2I^S;3G$VH5Z]6HHWCRK63Y>B_S=E\[G[WT445_/1Z 4444 %%%% !1
M110 4444 %8GB7Q'HO@_P]KGBKQ'?PZ9H/AS2K_6M8U"<D16>G:;;27=W.P
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?RW_P#!>GP8-/\ CA\$?'Z0B-?%?PNU7PL\BQ%!/<>"/%-WJ;L\@;9+
M,EOXZM8V.P2I"L"O(\?DI%^#]?U(?\%Z?!AU#X'_  1\?K"9&\*_%'5?"SR+
M$KF"W\;^%KO4W9Y WF10O<>!;6-CL,3S- LDB2>0DO\ +?7]1>'>*^M<)97=
MWGA_K.%GY>RQ5;V:^5&5(]+#N]*/E=?<W;\+!1117VQL%%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'YH?\%=O!A\7_L(_%>YBB,][X+U/P+XSLXUB61@+'QCH^DZI
M*&+*81;:#K>KW3RJ'8QPO#MVRLR_Q?5_??\ M8>#1\0OV8OV@?!BPK<7.O\
MP=^(=GIL;HL@&LIX6U.YT2;8^ S6^KP65PGS(P>)2DD; .O\"%?T#X28KVF2
MYCA&[O#9E[9+^6&)P]**7ISX>HUINWKV[L*_<DNTK_>E_DPHHHK]7.H****
M"BBB@ HHHH **** "BBB@ HHHH *_JT_X(O?M=?\+2^%5[^S=XRU+S?'/P:T
MV*Z\%S74^ZYUWX627,=I;VD88EWD\!ZA<VNB,<I''H.I^&;6WB;[%=RU_*77
MLW[/?QN\6?LY_&3P'\9/!DF=8\%:W#?36#R&*UU[1;A'LO$'AR_8*Y6QU_1;
MF^TN>54,UJ+E;RU:.\M[>6/YGBWA^GQ'DV(P-HK%0_VC 5967L\733Y(N72G
M6BY4*C=U&-1SLY0C;.K3]I!QZ[Q?9K_/9^I_H%45P'PK^)GA+XR_#GP;\4O
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M9GDD=F=W8LQ+$FHJ**_I#;8_#=]PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH _='_@D7X8-MX)^,?C-HN-9\4^&_#$,YC;@^&=)O-5N8HY22O(\6VKS1
MHJMQ TI<>2(_U_KX$_X)H^&?[ _93\,ZB8Q')XQ\3^,?$T@\LQN_E:N_A:&2
M3+$N9+;PS T<FU UN8=JLNV23[[K^8^+\1]:XFSFK>_+C)8>_P#V"1AA;?+V
M-C][X:H?5\ARRG:W-AHU_P#PIE+$?C[4****^;/="BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4,=M9V-C90I;6EG:6\2I%!;6UO''#!#$JQQ1(B(H50!^+7_!#?\ 9#_X9_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBO\ #"TI>=GHOF_PN?KC'&D2)%$B1Q1HL<<<:A$C1 %1$10%5%4!550 H
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MUS%1M=/V]>/)"<7:>'H4);MGL8:E[.FKKWI>]+NNR^2_%L****_.CH"BBB@
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M[O6+V?\ GV=T?Z0?_#<O[$__ $>%^RU_XD%\)O\ YKJ/^&Y?V)_^CPOV6O\
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M-?M>?\,C_M<>$=4\0ZI]@^%7Q4\CX8_%#SYO+T_3],UN]@_X1[Q?<[R88?\
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M\/P\_P#FBH_X:K_9>_Z.1^ G_AX?AY_\T5?YJ5%='_$"\O\ ^B@QO_A%0_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHLL3FXM;O56U80RVNE7A3X4569E55+,Q"JJ@EF8G 50,DDD@  9)X%?WI_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR7L:\O:0A%6A0KT(]&>QAJOM*:N_>C[LN[[/YK\4Q]%%%?G!T!1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?P[_\ !2WP8/ O[<_[1>DK"(HM3\:6_C.(I$8XYCX_\/Z-XVN)DRSB
M0F\U^Y2>56(:Z2<%8W5HD_N(K^2;_@N-X,.@?M=>'/%,,1%KX\^#_AC49KCR
MEC635]"UOQ-X<NX-X9C,\&E:=H,K2,$(2ZCA"E8@S?IWA1B?8\1UZ#?NXO+,
M1",>]2E6P]>+^5.%;[V=.%=JC7>+^]-/\KGXT4445_11WA1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!^Z'_!%?\ :['PY^).H_LQ
M^-=2\KP;\6;\ZK\/I[J11;Z)\38;1(9M*61R@AMO'.E6<%G$K/(#XBTC1+.R
MMUGUR]E?^J"O\YW2]4U'1-3T[6M'OKK3-6TB^M-4TO4K&>2VO=/U&PN([NQO
MK.YB99;>ZM+F**XMYXF62*:-)$8,H(_N6_8._:HT[]K?]GGPM\0Y);:+QSI"
MIX3^)^DPF"-K'QKI-M;B]U"*T@"BUTOQ+;R6_B'28UC$5O;Z@^F+)+/IMR1^
M#>*?#GU;%4^(<+3M1QDHT,PC%:4\5&-J-=I;1Q%./)-V256DI2;G7.+$T[/V
MBV>DO)]'\]O5=V?9E%%%?D!R!1110 4444 %%%% !7\^GQ,_X)(6WC#_ (*M
M>%?CS%H-LW[.'B&&?X\?$"S\N'^SW^+_ (7U&PBE\%RVOS^;;>._$]WHOC_4
M$O(GM=7L%\?Z9B%8+97_ *"Z*]K),_S+A^IC:N6UO92Q^7XG+J[U_@XF*7M(
M6:Y*]&48U*-5>]3DG;24DXG",^7F5^649+UB_P GLPHHHKQ2PHHHH **** "
MBBB@ HHKB?B1X_\ #OPK\">*?B'XLN3:Z!X3TFXU6_9-AGG,>V*TT^S61T27
M4-4OI;;3=.A9T$]]=V\)==^X73IU*U2G2I0E4JU9QITX13<IU)R480BEJY2D
MTDEJVTB9SA3A.I4DH4Z<93G.3M&$()RE*3>B48IMOHD?FW_P4\_:,/@OP39?
M KPO>^7XE^(5F-0\830.PETOP+'</%'IY=2ICG\5ZA;2VTBJ[_\ $ET[5+:Z
MA$6JVTC?@37HGQ9^)?B'XP_$7Q;\2?%,N[6/%>K37[P+(TD&FV2JEMI6CV;.
M YLM&TR"TTRS+CS&M[6-Y2TK.S>=U_3O#&24\@RC#X*T7B)+V^-J1L_:8JHE
MSI2ZPI)1HTWI>%-2:4I2O^!Y_FT\XS*MBKR5"+]EA8._N8>#?*[/:51MU9KI
M.;BG:*L4445] >*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %;7AO1+CQ+XBT#PY9[OM>OZUI6B6NU&E;[1JM]!80[8T!>1O-G7"("SG"
MJ"2!6+7TK^QUX9/BW]J#X(Z3Y1F$'CS2_$,D85G#1>$%F\6S%U7K$D6B.\P;
M*>4KF0&/<#RX[$+"8+&8I[8;"XC$/THTIU'_ .DG1A*+Q.*PV'6^(Q%&BK;W
MJU(P_P#;C^K.TM+>PM+6QLXE@M+*W@M+6!2Q6&WMHEA@B4L68K'$BH"S%B ,
MDG)JQ117\E-MMMMMMW;>K;>[;ZMG]())*R5DM$ELEV"BBBD 4444 %%%% !1
M110 4444 %%%% !7\4?_  7(_8F/[/WQ^3X_>!M&6T^$_P"T#J-[J&H1V4"Q
MV'ACXM+')?>*-*9(ALMH/%T(E\8:4KE?M%Z_BJWMHH[724 _M<KYH_:^_9H\
M)_M=?L]_$3X%^+/)M1XJTEI_#&OR0)/-X3\;Z63>^%/$UME&F"Z=JL<*:G#:
MO!/J>A7.K:,9XH=2F:OL^!.*)\*\08;&SE+ZAB+83,Z:N^;"59QO645O4PLU
M&O"RYI*$Z2:561C7I>UIN.G,M8M]&NE^SV?W]#_-NHKM?B1\/?%WPE\?>,?A
MEX]TB;0O&?@/Q'JWA;Q+I4^&:TU;1KR6RNA#,O[J[LY7B\^POK=GM=0LI;>]
MM)9;:XBE?BJ_M*G4A5A"K2G&I3J0C4IU(24H3A-*4)PDFU*,HM2C)-IIIIV/
M%VW"BBBK **** "BBB@ HHHH *_N@_X(I_M>?\-*_LG:9X$\3ZI]L^*/[._]
ME_#OQ']HF\R_U?P7]EE_X5MXGEW,\LGGZ+877A:\N9Y);J\U;PEJ&I714ZC%
MN_A?K]#_ /@E_P#M</\ L>?M:^!O&^LZB]G\,O&CK\./BS&\A6TA\'^)+RT6
M+Q),A)17\%ZY!I7B>2=(I+M]+T_5M,M2O]JS;O@_$;AG_6;AK%4:-/GS' 7Q
M^765YSJT8OVN&C;5_6J'/2C"ZBZ_L)R_AJV^&J>SJIOX9>[+R3:L_D_PN?Z#
M-%,CD25$EB=)(I$62.2-@Z2(X#(Z.I*LC*0RLI(8$$$@T^OXS/9"BBB@ HHH
MH **** "BBB@ HHHH **** "OY>O^#A#]L**#3_!_P"QAX*U;-U>RZ;\1_C4
M+61AY5C;E;GX=^#;PKF.3[9=^9XVU.SD"36_]F^"[V-FBO'6OZ,_C=\7O"/P
M#^$?Q#^,WCNZ^R^%?AQX6U3Q/JNUT2XO?L,!^PZ/8>9A)-4UW4GL]%TF G_2
M-3O[2 <R"O\ -[^-WQ>\7?'SXN?$/XS>.[K[5XJ^(_BG5/$^J[7=[>R^W3G[
M#H]AYF7CTO0M-2ST728"?]'TRPM(!Q&*_8O![AC^U,ZJ9[BJ?-@LD<7A^9>[
M5S.I%NC:ZM+ZI3OB'9J4*TL++9M''C*O+#V:^*>_E%;_ 'O3TN>6T445_4QY
M84444 %%%% !1110 4444 %?TY?\$ ?V)?[7UC6OVUOB!I"/IFA2ZMX*^!]O
M?0;A=:Z8VT_QKX\M5E0*8M(MI9_!^C7<;21OJ-WXJ4K#=Z/;R5^"7[*O[.GC
M']J[X]_#KX%>"4DBU#QKK<<.K:S]G-Q:^%?"MBK7_BGQ7?H9(8VMM!T2WO+V
M.VDN+=M3ODL](M9#?:A:QR?Z,7PH^&'@[X*_#7P1\)_A]IBZ/X,^'WAO2_"_
MAZQ'E&86.EVR0"ZOIHHH%O-5U&82ZCJ^H-$LVI:I=7E_<9GN9&/XUXP<6?V5
ME4>'\'5Y<?G%-O%.$O?P^6*3C43MJGCIQE0CNG0ABD[-P9V8.ESS]HU[L'IV
M<]__ "7?U:9Z#1117\N'J!1110 4444 %%%% !117,>,/&W@WX>Z!?>*_'OB
MSPWX)\,:8F_4?$7BS7-,\.Z'8KAF!NM5U>YM+&#<%;:))U+[2%!(Q50A.I*,
M*<93G.2C"$(N4I2;LHQC%-RDWHDDVWH@.GHK\6/C[_P7=_8G^$4UYH_@"\\7
M?M >)+=9$4?#W2TTSP;#>)@K!?>-/%4FE17%O(I#+J'A32/%MID["X=9!'^.
M7QD_X.%?VL?&CW=I\(/ ?PR^"FDR^9]ENYK2Z^)?C&TW%A'G6?$*:;X3N/+0
MKG?X 7?*I<XC;R5^\RCPRXQS>,:D,KE@*$[-5\TFL$K/5/V$U+&.+6JE'#2B
MUL]5?">)HPT<U)]H^]^*]W\3^S2N)\7?$OX<> (_.\>?$#P3X)AV+)YOB[Q7
MH7AN/8[;$?S-9O[)=CM\JMG#-P"3Q7^>-\3OV^/VT/C$TH^(/[3/Q?U6SG>6
M2;1M,\8:CX3\.2O,&5R_ACP>^@^'6VHSQQ Z9B"*26* 1QRR*WR9<W-S>7$U
MW=W$]U=7$C37%S<RR3W$\KDL\LTTK-)+([$EG=F9B222:^_P7@7B9)2S'B"A
M2E]JG@L#4Q"?=*O7KX9KKJ\._0YY8Y?9IMKO*27X)2_,_P!%+Q%_P47_ &$?
M"S^7JG[6GP'G?S$B*Z!\0] \6;7D21P'/A6ZUD(%$3K*[E4@D,<4S1RRQ(_E
M=Y_P5Z_X)QV$=S+/^T_X9=;42-*+/PA\3=1D819W?9H=/\$W4UX3@^6MHD[3
M<>2'W#/^?W17T%+P.X>27MLVSFH]+NE+ T4^]E/"5VK]-7;S,WCJG2$%Z\S_
M %1_?AIO_!9'_@FQJTDL=K^TUIL30H'<ZE\-?C-HR$,=H$4NL?#FQBF?/6.%
MY'4?,RA>:[K0_P#@J=_P3W\0LB6'[57PSMR\SP ZY-K?AA0\<2S,SOXET?24
MCA*, ER[+;R2AH(Y6G5HQ_GJT5=3P/X::?LLTSR#Z.I5P%1)^:CE]*^O1-=K
M]06.J=80?HI+_P!N9_I5>#_VKOV7OB"UO'X&_:-^!?BZXNO)$-GX=^+'@35M
M0\RX$)BMY=.LM=FOH+LFY@1K2>WCNHY94BDA25@E>]12Q7$44\$L<T$T:2PS
M1.LD4L4BAXY8I$+))'(C!T="592&4D$&O\MNO3OA]\;/C+\)KE+OX6_%GXD_
M#BYC8LLO@7QQXF\*,=TGFNKC0]3L5DCDD):6*0-'*6;S%8,P/C8OP*@TY8#B
M*:DE[M/%Y>I)OI>M1Q4'%>E"1:QW\U/[I?HU^I_IM45_!Q\)/^"UW_!0;X5-
M;0WGQ5TCXKZ/;>7LT7XM^$=)\0+)L 5OM/B/0AX8\<W/FJJ+)Y_BM\$&2+RI
MI9I)/UK^!?\ P<9_#_5I;32_VB_@1X@\&NP2.;Q=\*M9MO%VE-.[ &>Y\(^(
MO[ U;2K&($F0V?B+Q1>D#,5I(QV5\/FOA'QCERE.AAL+FU*-VY9=B4ZJBN^'
MQ4<-6G+^Y1C6=]KK4WABZ,M&W!_WEI]ZNOFVC^ERBOEG]G_]MG]E;]J&)!\$
M/C7X-\8ZL8?M$OA-[N?P]XXMHE4-++/X)\36^C^*!;0,?+DOHM*ET_S 1'=R
M JS?4U?G&*P>+P-:6'QN%Q&#Q$/CH8JC4P]:/^*E5C":^<4=":DKQ::[IIK[
MT%%%%<XPHHHH **** "BBB@ HHHH **** "BBB@ HK^$O_A^1_P4:_Z*UX5_
M\-/\./\ YG*/^'Y'_!1K_HK7A7_PT_PX_P#F<K]?_P"(*<6_]!>1?^%F-_\
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M6\#4E&ET2H5</&*M3DSS,92Y9>T7PS?O>4O_ +;?U3[H^8Z***_:#B"BBB@
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MDO9UIJK"$4HPH8BC"/PNWKX6K[2FDW[T+1?FOLOYK3S:;):***_-3I"BBB@
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M5).3T_@U*LI/EI11RXFG>/.MXZ2\X]_D_P &^Q_0G1117\_G"%%%% !1110
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M@_\ M+]GGX1>.(TWR^%/BZV@R$#+16/C#PEKEU-,WRX$7VWPGIL#'>#YEQ"
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M#9Y(A+:^'8O%'B6Z!V_)_9WAC58=/E&_/,>LWFF/\JLV 2NW_6)_3O7X&?\
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MZ6O^?O\ \.B?^"C7_1K_ (J_\*GX<?\ S9T?\.B?^"C7_1K_ (J_\*GX<?\
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MNU)W7MZ_GSSBH0=VG3IPDK.4@HHHK[4^5"BBB@ HHHH **** "BBB@ HHHH
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M&H3^([RVD\ZUN9_%FB2D)>Z)\G\U-=M\2OB'XK^+7Q!\:?$_QSJ3ZOXP\?\
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M>SU'3-2MHKRPOK29"4FMKNUFBN()5)62*1'4X(K1K\:?^"&_[2;?'']B_2/
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M*^'GBOX2_$'QI\,/'.FOI'C#P!XGUKPEXCT]BS);ZMH5_/I]X;>5D075E-)
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MFK7M)RL[6"BBBO=/("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK5S)_8OE;SYD_P#PA6LO<^&Y]@$-AHEYX/M5^9S7[WU_G(_L+_M0:O\ L?\
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MM5+&58/G5[_5Z4X3BX8B+?=@Z/-+VLMHZ1\Y=7Z)?>WY,W****_F<](****
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MC13O2HMK9U9+GFM&J<()WC59!1117[4?E@4444 %%%% !1110 4444 %%%%
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M+X U61O&/PCUNY,DPU;X>ZW<W!TVTENY"6N-6\+W4-YX5UN24137.H:0^J+
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MZ&(C;;EK4HU%;RM+0]=.Z3[I/[T%%%%= PHHHH **** "BBB@ HHHH ****
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M,9BZV/Q5?&8B7-6Q%252;Z*^D813O:$(I0@K^["*70****ZSF"BBB@ HHHH
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MHF\5?$_7[>.)3XB^(NNP6SZ]<B6-5-QI^CQ067AC09) )3H&AZ8T^;EYW?\
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M2_:-+O9[&?S+:4F6WD\V!M\$A,D39C<[E-?T+X$35N)Z7VKY/->:MF<7_P"
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MNOZR?^#;?0Q;_#K]JCQ+Y<(.K>-?ACH9E5&%PX\/:%XNOQ'+(5"O#$?$Y:!
M[-&\URS*@D4O^=^*\XQX#SJ+WJ3RR$?.2S; U/\ TF$CHPG\>'ES?^D27ZG]
M+]%%%?QV>P%%%% '^6O1117^A!\^%%%% !1110 4444 %%%% !1110 4444
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M333::>C33LTUT:>C/Q^490E*$DXRC)QE%JSC*+LTT]4TTTUT84444A!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z
MQ_\ !)/PP;WXK_$_Q>T(DC\/> ;/05E9 P@N?%6OVM[$R,<^7,]OX5O(U90'
M,+3IN",ZM^]M?DM_P21\,_8_A=\5?%YB56U_QWIOAX2[0))8O"N@0Z@H+9W/
M%')XNF$>1L61IPI+>8%_6FOYOX]Q/UCBC,;.\:'U;#1\O98:E[1?*M*H?N/!
M]#V'#^"NK2K.O7EY^TKU%!_.G& 4445\>?3A1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y[\6/A=X-^-?PU
M\;_";XA:8-7\&?$#PYJ7ACQ!8@HDQL=2@:+[58SO',+34].G\G4-*OEC>2PU
M*UM+V(>; AKT*BKI5*E&I3K4IRIU:4X5*52$G&=.I3DI0G"2LXRC)*49)W32
M:U#?<_S6/VI?V>/&'[*OQZ^(WP*\;*\NI^!]<EMM.U<0-;VOB?PS>HE_X8\4
MV",746NO:)<V5^85EE:PNI+G3+AQ>65RB?/U?V<_\%W/V*/^%U_ ^T_::\"Z
M1]H^)?P"TVY_X2Z*TBW7GB7X-RSR7NL>8%C9Y[CX>W\]QXJM-TL$-OX>O?&L
MC_:KHZ= O\8U?VKP/Q/3XJX?PN/;BL=12PF9THV7)C*48\]117PTL3%QQ%)*
MZC&HZ7,Y4YV\6O2]E4<=>5ZQ;ZI]+]UL_OZA1117V!B%%%% !1110 4444 %
M%%% !112JK,RJJEF8A5502S,3@*H&2220  ,D\"@#[T_X)P?L=:E^VI^T]X0
M^&]S;WL?PW\/,GC7XO:S:B2(6'@71[JW^TZ3!>JI6VU?Q=>R6OAG2&7S)[9]
M0N=86VN+71[T)_H2:3I6FZ%I>FZ)HUC:Z7H^C:?9Z5I6F6,$=M9:=ING6\=I
M8V-G;1*L5O:VEK#%;V\$:K'%#&D:*%4"OS$_X))_L4#]CG]F'2CXKTI+/XT_
M&#^SO'?Q2>54-[HHDM7_ .$2\ 22*BE4\':3>3'4H-TZ1^+=9\4-;W=Q8/9&
M/]2J_C[Q-XK_ -9<_G1PU3GRK*74PF!Y7>%>IS)8O&*S::KU(*%*2=I8>C1D
MDI3FCU\-2]G33:]Z=I/NETC\MWYMA1117YP=(4444 %%%% !1110 4444 %?
MRP_\''_PAV7O[-WQ[LK7/GVOBOX0^)+W9C;]DFB\9^";7S #N\S[;\0)=CE=
MGE[HPV^4I_4]7YH?\%=_@3+\>_V#/C1I6FVC7GB7X<V-I\9/#$:0M<3?;/AV
MTVI:_';01D2S7E]X&G\6Z99Q1;I7NKZ$1Q3,1#)]CP!FJR?B_),7.?)1GBU@
ML0V[15''QEA)2G_<I2K1K/LZ:>MK&.(AST9KK;F7K'WK?.UOF?P#4445_:YX
MH4444 %%%% !1110!_H(?\$LOVKK?]K7]C_X>^*M3U(WWQ'\ 6T/PP^*B7$X
MEU"7Q7X6L;.&V\17).V24>,?#\ND^)9+H1);_P!J7^K:="\LFEW##]&*_@O_
M ."1G[<<?[&O[2-O9^-=5:R^!_QE&F>#_B:\SXLO#=Y!<3_\(A\0I5 W"/PK
M?ZA>VNL,K$)X6US7KE;>\OK/3H1_>9%+%<113P2QS031I+#-$ZR12Q2*'CEB
MD0LDD<B,'1T)5E(9200:_C;Q'X7GPUQ'B%2I..69E*ICLNDE:G&-27-B,(FE
M92PE:;A&%W)8>>'G)WJ'LX:K[6FKOWHVC+U6S^:U];KH24445\ ;A1110 44
M44 %%%% !1110 4444 %%%?DS_P5X_;IL_V/_P!G;4/#7A'5DA^.GQIT_5O"
MGP]@M+@+J/A71Y;<6GB?XC2*F7MO[!M;M;+P[(Y1KCQ3?6$\,=U::3JZ0^EE
M&58S.\RP>58&FZF)QM:-*"L^6$7K4K5&K\M*C34ZM67V:<)/6UB9RC",IR=E
M%7?Z)>;>B[L_F=_X+)_M4P_M-?ME>*M/\.:C'??#CX'6S_";P=-;2E[/5-1T
MB]GN/'?B.+#/#*=1\6RWVDV=]:R-;:CX>\/:!>1G,K9_)^E9F9F9F+,Q+,S$
MEF8G)9B<DDDDDDY)Y-)7]RY1EF'R;*\!E6%5J& PU+#P;24IN$??JSMI[2M4
M<ZM2VCG.31X<YN<Y3>\G?_)?):!1117HDA1110 4444 =K\-O NL_%#XB> _
MAKX=1I-?^(7C+PQX(T5%B:<MJOBK6K+0]/\ W*%7D NKZ(LBLI901N7J/]-7
MPMX;TKP;X8\.>$-!@:VT/PKH.D>&]&MF8.UOI6AZ?;Z7IT#,%0,T5G:PQE@B
MABN0J@X'\0/_  0V^ TGQ@_;G\,>,+ZT:;PQ\!O#FM?$_4Y)(/,M)->,2^&/
M!=BTI!6&^CUW75\2V(^^Z>%KLH1Y;$?W.5_,WC?FJQ&<97E%.5XY=@ZF*KI/
M18C'SBHPDOYH8?#4JD;[1KZ?$ST\#"T)S?VI)+TBO\VU\@HHHK\0.T**** /
M\M>BBBO]"#Y\**** "BBB@ HHHH **_6C3O^"(W_  41U33['4[/X3^%I+/4
M;.VO[21OBK\.HV>VNX4N(':-_$2NA:*1&*. RD[6 ((JY_PXW_X*-?\ 1)?"
MO_AV/AQ_\T=?-OC+A)-I\2Y$FG9IYI@TTUNFO;:-&GL:O_/N?_@,O+R\_P"K
M,_(NBOUT_P"'&_\ P4:_Z)+X5_\ #L?#C_YHZAN?^"'W_!1JVMKBY/P@\-SB
MW@EG,-M\4_AS/<S"*-I#%;PKXCW33R;=D42_-)(50<D4EQEPDW9<39%=Z+_A
M4P7_ ,N#V-;_ )]5/_ )?Y>?Y]F?DC15J^L;W2[V\TS4[.ZT[4M.NKBQU#3[
MZWFM+VQO;29[>[L[RTN$CGM;JUGCD@N+>>-)H9D>.1%=645:^E332::::NFM
M4T]FGU3,PHHHH **** "O2_@WXO\)^ /BM\/O&GCSP'I7Q0\%>&?%FC:MXK^
M'VM23Q:=XMT"UO(VU71YI+>: I+<V?FFS:X,]@+U;?\ M*RU'3OM5A<^:45G
M5IQK4JE&?-R5:<Z<^2<Z<^6<7&7)4IRC4IRLWRSA*,XNTHR4DF"=FFMT[KKM
MY/1_,_TU_@EXB^%OB[X2?#SQ3\$X/#]K\)_$/A72=8\!6GA;2K/0="L_#U_;
MK<VEG8Z'86]I:Z,;0R/;7>DI:V\FG7T5S9W$$5Q#+&OJ-?R:_P#! W]N@>&/
M$=[^Q5\2=9\O0/%UUJ/B7X&7M_,B6^D^+62XU'Q7X#6:7B*W\5PQR^(?#]N9
M(8%\16>M6<*W.J>*K2$_UE5_$?&'#N*X8S[&9;B)5*M-R>(P>*J7<L7@ZTI.
ME6E+[51-3I5[:+$4ZJ5X\LG[=&HJM-26G22722W7Y->304445\N:A1110 44
M44 %%%% !1110 4444 8'BKPMX=\<>&M>\'>+M'LO$'A?Q1I-_H6OZ)J40FL
M=4TG4[:2TOK*YCR"8Y[>5T+(R21DB2)TD5'7^3__ (*"?\$I_&'[.KZS\6/@
M;;:MX[^!D:S:CK.E?O=2\8_"^!2TEPVJI&AGU_P=:Q_OHO$T"/>:1:I.GB>W
MBM[(>(-3_K?IKHDB/'(BR1R*R21NH='1P59'5@5964D,I!!!(((-?2<-\49E
MPSBO;8.?M<-5E'ZW@:K?L,1%:7TNZ5:*NJ=>"<HO2<:E/FIRTIU94W=:I[Q>
MS_R?9_FM#_.1HK^F+_@H/_P2%LO$G]N_&C]DW1K;3/$.V?4_%7P5L5@M-*UQ
ME_>76I?#I"8K?2M68>9/<>$F=--U(Y7P]]@OA#I.I_S4ZCIVH:1?WNE:M8WF
MEZIIMU/8ZCINHVL]E?V%[:RM#<V=[9W*17%K=6\R/%/;SQQRPRHT<B*RD#^E
ML@XCRWB/"+%8"K[\%%8G"U&HXG"S:^&K!-WB]?9U87IU$GRRYHRC'T85(U%>
M+]5U7JOUV*=%%%>\6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF0RR/-.RI-J>IW.H:O> WNH7#-UW[9G[:GQD_;=^*4WQ$^*>I):Z5IGVRQ\
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MQ2U\I_LM?%$^+/#+^#-7N?,U_P )V\8LY)7+3:CX=W+#;298DM)I,C1Z?-T
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MJ&UFO;:*2(ZGI3:AI$T@M=0G5O\ .?\ B9\./%_P@^(/C+X7^/\ 29=#\9^
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M4C@EADN=$\0:5/>Z'K=FLL?VS2=0O+;>GF[A_HL_LR?M">"/VIO@;\/OCGX
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M7DN_=O=OJ]3X^I4E5J2J3=Y3;DW^B[)+1+HDET"BBBJ("BBB@ HHHH ****
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MIQC..TE?_->J>C\T%%%%>:4%%%% !1110 4444 %%%% !1110 4444 %%%%
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M;V5Y2>D8I*,(1M"$4H0C&*27H1C&*48I)+9)604445RC"BBB@ HHHH ****
M"BBB@#_+7HHHK_0@^?"BBB@ HHHH **** /]/[P+_P B1X-_[%7P]_Z:+.NJ
MKE? O_(D>#?^Q5\/?^FBSKJJ_P ^ZW\6K_U\G_Z4SWX[+T7Y!11168PHHHH
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M_G<EHHHKX(W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_"/\
MX*$?\$C]&^*!UKXR?LO:7IGAOXD2&XU+Q1\+HFM-)\+^.IB))[C4/"[/Y%AX
M:\77,N3<64\EKX<UV:07$DVB:B+N[U?]W**]?)<\S'(,9'&Y;7=*HK1JTY7E
M0Q%-.[I8BE=*I!]-8S@_>ISA-*2N$Y4Y<T79]5T:[-=OQ[-,_P Z37="UOPQ
MK.J>'?$FD:GH'B#1+^ZTO6=$UFQN=,U;2=2LI6@O+#4=/O8H;NRO+6='BN+:
MXBCFAD5DD16!%95?VI_MU?\ !./X7_MB:--XBT\6'@#XXZ;9F/0_B%:V9^RZ
M[';Q,MKH/CRSM5$FKZ42(XK75TCEUW055&L7N[!;C1KW^0;XU_ [XH?L]>/=
M4^&_Q:\*WWA7Q/IA,D<=PHET_6-.:66*VUO0-3BW6>LZ+>F&3[-?V<DD>^.6
MVG$%Y;W-M#_2?"W&&7<3T+4VL-F-*">)P%2:<U:R=7#R=O;T+_:24Z;:C5A#
MF@Y^A2JQJ+322WCU]5W7G]YY+1117UQJ%%%% !116;J^IV^CZ?<ZA<'Y($RJ
M9 ::5OEBA3/\4CD+G!VKN<_*K$.,7*2C%-RDTDENVW9(4I*,7*32C%-MO9):
MMG _$7Q!]FMUT.UDQ/=*)+YE/,=J2=D&0>&N&&YQU$*X8%9A7B]6KZ\N-0N[
MB]NG\R>YE:61NV6Z*HYVHB@)&HX5%51P!56OJ,-06'I1IJW-\4VNLVE=^BV6
MVB76Y\CB\1+$UI5'=1^&G%_9@MEZOXGYM]+!1116YS!1110 4444 %%%% !1
M110 4444 %%%% !1110!]:_LK?%'_A&?$4G@76+D)H?BBX5],DE<B*P\1;%B
MB09.U(]8C2.S?J3>0V &Q7G<_I'7X4H[Q.DD;M')&RO'(C%'1T(9'1E(965@
M&5E(*D @@BOUJ^ _Q/C^)?@JVN+R9&\2Z&(=,\11<+)+.L>+750@P!%JD,;3
M,558UO([V&-52%<_,9W@^62QE./NS:C6MTGHH3MVDO=D]N91>\FS\^XNRKDG
M',Z,?<J.-/%)+2-2RC3JZ=)I<DWHN=0WE49[91117SQ\0%%%% !116OH&@:W
MXJUK3/#GAO2K_7->UF\AL-*TC3+:6\O[^\G;;%;VUM"KR2.QR3@81 SN5168
M*4HQC*4I*,8IRE*32C&*5W*3=DDDFVV[):L:3DU&*<I2:48I-MMNR22U;;T2
M6K9D5^MW['?_  3IU+QE_9/Q-^/FGWFC>$F:*^T+X=SB>QUOQ-$/GAO/$H!A
MN]#T*4[6ATY6AUC58\R2G3; P2:E]._L=_\ !/;1/A5_9?Q(^,UK8>)/B5%)
M#J&B^&]T5]X=\#S)MDM[B4@/;ZYXFMI )5O<R:9I-RJMI:W-W;P:M7ZBU^/<
M6^(#E[7+<@JM1UIXC,X/6724,$^BW3Q6[U="RY:S_3>'.#.7V>.SB"<M)T<!
M+5+9QEBUU?7ZOLM%6;?-25+3=-T[1M/LM)TBPL]+TO3;6"RT_3M/MH;.QL;.
MVC6*WM;2TMTC@M[>")%CBAB1(XT4*B@ "KM%%?D3;;;;;;;;;=VV]6VWJVWJ
MV]S])2222222222LDEHDDM$DMD%%%%(84444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% 'AO[2?P#\%_M/?!#XB? [Q[;I)
MH/CS0+C38[[R(Y[K0-;A*WGAWQ/IJR8 U+P[K=O8ZO9_,J2R6OV:;=;SS1O_
M  C_  1_X)^?%KXD_MS+^Q7XCL;G0O$'A3QEJ%G\4];M87FMO#GP_P##<]O=
MZ[XUL'GCC2>QUC0[G3Y_!D]RL%OK5]XC\-0,\*:FKK_H55YGI?P?^'FB_%GQ
M=\;M-\-Z=;?$KQQX/\*>!O$GB2.UM4O;[P_X.O\ 7M0TF!IT@6Y\Z6371;ZE
M,\[F_L]#\,VLJ^7H-B$^_P"#N/,=PE@<ZP5&+JPQ^&E/ IM..#S3W*,<5RRO
M%P]@Y2JPL_:3P^'B[1YC"M0C5<&].5Z_WH[M??MVNSH_ _@KPQ\-_!OA;X?^
M"M(M= \(^"] TKPQX;T6R01VNFZ+HME#8:?:1#JWE6T$8>5RTL\F^:9WED=V
MZFBBO@ISG4G*I4E*<YRE.<Y-RE.<FY2E*3NY2DVVVVVVVWJ;[;!1114@%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTXRDX4H?W*<8P72)TQA&"M&*BNR5O^'"BBBO.*"BBB@ HHHH **** "BBB@
MHHHH **** /Y&/\ B' ^-O\ T<C\+/\ PE/%O_QRC_B' ^-O_1R/PL_\)3Q;
M_P#'*_KGHK]+_P"(M\<?]#+#?^&W _\ RC^KORMS?5*'\K_\"E_F?R,?\0X'
MQM_Z.1^%G_A*>+?_ (Y1_P 0X'QM_P"CD?A9_P"$IXM_^.5_7/11_P 1;XX_
MZ&6&_P##;@?_ )1_5WY6/JE#^5_^!2_S/Y&/^(<#XV_]'(_"S_PE/%O_ ,<H
M_P"(<#XV_P#1R/PL_P#"4\6__'*_KGHH_P"(M\<?]#+#?^&W _\ RC^KORL?
M5*'\K_\  I?YG\C'_$.!\;?^CD?A9_X2GBW_ ..4?\0X'QM_Z.1^%G_A*>+?
M_CE?UST4?\1;XX_Z&6&_\-N!_P#E']7?E8^J4/Y7_P"!2_S,?P]IKZ-H&AZ/
M+*DTNDZ/IFFR31@JDSV-E!:O*BM\RI(T1=0W(! /-;%%%?FLFY2<GO)MOU;N
M_P 3IV"BBBD 4444 %%%% !1110!^$W_  4?_P""-,7[9/QDTWXW_"GQ[X7^
M%GBO6-$CTKXG6VO:)J6H6'BO4-'CM;/PYXDM3I+I)#K"Z/&=%UAIU,5U9Z7H
MDD02XCO9+C\\?^(<#XV_]'(_"S_PE/%O_P <K^N>BOO<M\2^,,JP.%R["9E3
M6%P=)4,/&M@\+7G"C!_NZ;JU:4JDHTXVITU*3Y*<8P7NQBEA+#49R<I1=Y.[
MM)K7T3/Y&/\ B' ^-O\ T<C\+/\ PE/%O_QRC_B' ^-O_1R/PL_\)3Q;_P#'
M*_KGHKN_XBWQQ_T,L-_X;<#_ /*/ZN_*T_5*'\K_ / I?YG\C'_$.!\;?^CD
M?A9_X2GBW_XY1_Q#@?&W_HY'X6?^$IXM_P#CE?UST4?\1;XX_P"AEAO_  VX
M'_Y1_5WY6/JE#^5_^!2_S/Y&/^(<#XV_]'(_"S_PE/%O_P <H_XAP/C;_P!'
M(_"S_P )3Q;_ /'*_KGHH_XBWQQ_T,L-_P"&W __ "C^KORL?5*'\K_\"E_F
M?R,?\0X'QM_Z.1^%G_A*>+?_ (Y7]%W[%7P=^-G[/?[/?@[X,_&7Q_X9^*VN
M?#X3>'O#/B_1X];TZ67P':16P\,Z/K":M%=S7&H^'HS=:):W,#1P'0+'1(&C
M:[@NIY_KFBO"S[CCB'B7"T\'G&(PV)HT:RKTN7!86C4IU5&4+PJT:<*B4HR:
MG%2Y9Z<R;C'ENG0ITFW!--JS]YM6]&[!1117R)L%%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \@^.GP&^%/[27PVU[
MX3_&3PCI_C#P9K\0$UI=!H;[3+Z+)LM;T#5("E]HFN:=(3)9:GI\T-Q'F2"0
MRVEQ<V\W\.'_  42_P""9'Q7_85\52:U +_Q_P# #7]2-MX-^*%O9_O=-FN
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MG3E"<O)G"5.3C-6:^YKNGU7]/4****]<@**** "BBB@ HHHH **** "BBB@
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MHZE>O6ES5*DWI=O91BDHPA%*$(*,(1C"*2]6,5%*,4DEHDMD%%%%<HPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>vor-20251102.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-11-03T07:30:04.2027+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://vorbiopharma.com/20251102" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:vor="http://vorbiopharma.com/20251102" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="vor-20251102.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10200.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 02, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  02,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VOR BIOPHARMA INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001817229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-1591163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 Boylston Street, Suite 1350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">655-6580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VOR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="vor-20251102.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="vor-20251102.htm">vor-20251102.htm</File>
    <File>vor-20251102.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "vor-20251102.htm": {
   "nsprefix": "vor",
   "nsuri": "http://vorbiopharma.com/20251102",
   "dts": {
    "inline": {
     "local": [
      "vor-20251102.htm"
     ]
    },
    "schema": {
     "local": [
      "vor-20251102.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_bb4ba679-5702-494c-8228-5e49f4a42304",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vor-20251102.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_bb4ba679-5702-494c-8228-5e49f4a42304",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vor-20251102.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://vorbiopharma.com/20251102/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-25-261723-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-261723-xbrl.zip
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M.4J:L[$^4YZ][?C^W+F\>_8>Z(*O"0]LT+9!VP9M&[0]#=HVP9ZG\MO\0,>
MCDUUQ@UJVJY//<DEU0S?TP*=>;:V),=]3XA49EGUYW,82[92.\?2-/(Q&499
M#C;-69Y*F3?(60&=$&98VKW]^A&MZ*^/5EX61S\C!\]8KWANCM8=[K299E#;
M8C8U9="FKB\E-7U=VB9CKNT].O=B@J/WX>=Q>IY<K38B^S%!3I[#MJL#I[%
M6HQIZ:XON$U]AW-J"AN$K1\X5+.UP#*DZQH.7^K4J##&<7J2)I>AVB&V3B'U
M+SS+N-\K,IGGV1L,J]YO@?.9+<]R "]6* K#"#A(0&I[/HA"W3&I*^#1M4 H
M"JVM2<==*N>=@'3BT;_"@5K*6NE*A<Y8>Q.6?I6ANHJX,+_E) 6)'@YX1 ZO
MI5_@#C1R' 2A+[-UC)&^6$-U$UI^!+V"_",H .?$CV^GMCZ[NGW#^41KG^;/
M=&O=!=8:YOG?)$3^\+VC,WLG(^<RDH,>5*H6U]19(%&!^"%[,&N*=SN/\:46
M@FP1S\GCS&&!3PWA"O"<=(,ZS#=H( SI>[KNMWW_L?8;^K$XZI5;;&UF/X$;
MNRS4V[HM7+>M4UWMJO292[TV&-&&;]N>TS8=PW(>B_K/"?#M"5+B,R1SM"V+
MMBWG7A' C>IZ7:KKC:NK=0@$KX23UGX3PZ<D!;%#CM0NAI14CY7?UR!A@#L7
MX@LIR!E&],AGGN75UKU'[V5H&IM]8G.W,M\725.[F6<-^7Y',2P/ ?L]Z7]5
MNY/Y8) F@S3$I#>0E<2347*%Q(8?D0:)0W\E 8AAL S#C(38A  BS!.2A?TB
MRGDLDR*+AB3C>9@%0U6SJI!X,/0REZC:#9W>;,XIH)V4\'A8?PM RB=76 _C
MTB$F@&6/LD&7C38R3C)CQP^I6<;C@>*\0W53284)J5^]F]J.=4^]/\%/3/9W
M;KVX<W/>7!S<L3FO'=B.9P4&=37?IV;; U7I@#7G.M)RF&.ZMO'HX.D_TS '
M_&+27Q%7F6?9[?4*+TDBCP.!Y$"FCQGH#]^[MFGNS+/YUH?J*@0!FL<Q1 9C
MQP^<%F"1F;I5\=34L0-XVL VL\G^IU,"V&]"P1N-@2=A/9*6VR^"EDVN2UWG
MX$,:#OSG>B;EIK!HH+F:!MZDXS_^C)@S4( ^(#V^^ ("%:1JM"'D&T*^P0[I
M5^BY3<7,Y)3I8X0\<6C&B(Q-L*Y5R3=(R<P(;-?77>I(9E%39SIU76%3P8RV
M)DP96.S14ODDE2B1\1A#=>@1*OWT. CP1+P-18^.@('6_3$TS971S!14W_;>
M+4;?9=DW2.&:H3'?<UUJNUZ AP)XU+/L-I6ZQ^PV%Z;EVTNF\&Z6%3+=T/F2
MZ-R0U,1CJ!>A\ZKL%)TO_70I=P6G2RU16=[8;Z7/)%/PN@:SSIQ2 J7RH0"Y
MG1<1L#,>LCO\(7O7F;6BCLSY'3U5[N/25ZFGPSOZ*+RS;ED_JUDI4+NCSO&H
M\?* ++]7'AN\PL2!NZ>$?!^H?YJQ267;$/OCB?T\Y3CH\N#B81]J;Z\TLVA#
MZ1M*7Z%8/ZK.C5)27=96*AA6T!N\N;&^5KJ=X6UN80@<(;CG@L_'N4/-0&K4
MU?TV;7N^8&U7=P+WT8=)5);UD.F>TN@/I+C%%EK 3U*;CA+_:X/\'\R@IC$"
M%C2YY%$AR0#O;NB]S=-E7H- ?1%,I>L^UUW;H5QZ/A[1$U#'-CGUX&W '4M:
MAG@L4U4V0VDN/"5'_7%\NN&5#:\\%:\8ANOIP@^HY6J@A=JF25WN6]1NZ[YG
M:P9;0N2Q5D!U1$P=1WHKVHB6R*/V9BUV0C'/!/^+_!0E'MX-)R/IY^0+3[_*
M_,FSXN:>Q7Y/AGBNZ&@W%A@)E<0;$E]E5@#@7\%\E.H(H:FTAS C +($9%[@
M2MA%FESE/0RH#C 5@F=$R"",R_-*RW5=S9IQEOS-$?(&V49>MG<PN]=P=]02
M;UT'>@,B&^"!IYA55 9G=8_J"QY//]TVQFMOJH^UWERG>/5$HL;3WMZP3H1X
M> =1S;ET!0&X8R%&=WR-L4"CM@GRS0PL'8T(DWJF=()V6VJN8RUG]UP-^T\*
M]/T2\J=>@VG/78-Y4_33#;XAFAH@D&;*N?!69E</I)C2)"#%XD0M5A295*5@
MX%7^&-[TJ.Y1(^4E<#C5JJ]HB)U?A= U$F\, X$OJ;P,,Z@7C"XRY;Z/9X9B
M8;P&4_!49&7FF+AKI<38YJ.5DG%IUWP$BS#=UWPA/>H(RZ*FK7/J!)I)+4<$
MCF6!/RN6M+7[\/I\A+3R[H/G7Z-\BJ.@)Z-4LV_16^-<TF]?4!A$\IJ*,"U)
M$A?*BGZ\4U\!BE]OWV&(MXF&P;#N596BP$9S+C?LC>)1%8;+BU:INJ^Q7.J;
M_ !-EJ\'_$*6,2O* ]#N'1Y=\6%6K6.MU\V+"UVB-N^*K1>3N=O-99]834TG
M![@0F^.5TR#0#A1!)6F&HG(?W#% 8;4I.,UVR&%42<#QHCMD;S!(PCA7*_KP
MY78]5,,RSC@4'Y*]-$5YB:6S6<5O+BJ8N&-L.5)!^0IC<U*QQ+I,RS$>EEC=
M]5)=]4*V4<N@W:QK.X=!(-5-X>I.;_62[;QKD#]@NC[6MR^7]W&/5ZO,H+H\
MZ$-!#M(F^0V5WK^*E%\UE"X;*Z>V]^WW0@DS+2]EE S4]%:3U"#*!U;>!2A&
M0!ROKP2>A%>="JE>[UVDLDSZ&-T>/(('FD!P%"2CSN5-73ZJJ]3Y&*@$;^@1
MY)<B&A)FS\+8# CJ?IOD'!7X-V&L+8$,>N4PN/ =.E08@E", )!C9XGRT#)
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MXXRIF0EU>'>F+*M^\Y[] G[Y=D%A:348NQXS3$\@!=3Z2O&]U@RI 520%2Q
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M^V9W*_P@_O]02P$"% ,4    " !/0&-;L#XU>,\5   ;NP  $
M    @ $     =F]R+3(P,C4Q,3 R+FAT;5!+ 0(4 Q0    ( $] 8UNKH1W;
MFP@   YA   0              "  ?T5  !V;W(M,C R-3$Q,#(N>'-D4$L!
M A0#%     @ 3T!C6VTU=(<U#0  \S\   X              ( !QAX  '9O
B<BUE>#DY7S$N:'1M4$L%!@     #  , N    "<L      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>vor-20251102_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vor-20251102.xsd" xlink:type="simple"/>
    <context id="C_bb4ba679-5702-494c-8228-5e49f4a42304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
        </entity>
        <period>
            <startDate>2025-11-02</startDate>
            <endDate>2025-11-02</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_d269f412-7bbb-4e27-99ca-f6eeb2d2d31c">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_a2ae7a8b-4a73-4f15-851c-a21115fe8a20">0001817229</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_549c51ef-d6e0-4922-8f34-449c74f5ee43">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_8e00f74b-192a-4c8d-92b2-e3acb3f65b40">2025-11-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_3cb19f6f-2933-4b97-9852-68989e38d1d1">VOR BIOPHARMA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_42afa5b0-01a1-481d-87dd-901d341a30c1">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_e4f50a0e-1df1-4052-ba53-61091314dd5e">001-39979</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_70cafe6c-ee5d-4242-b3f2-235351ec3bb2">81-1591163</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_cf2a30c7-21a3-479c-beae-03cb0f21b70e">500 Boylston Street, Suite 1350</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_28a86103-7517-4ef6-9cee-4c2e741197b0">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_4529cda7-c8aa-4d7c-bcf8-070f53e9938a">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_d33fa4c2-7bce-4284-9dc2-952e7d060e89">02116</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_4ba181fc-3d9d-4d23-81c3-fd3ecb22c6cc">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_727d9962-26e0-4c19-b6ce-3c77b8648358">655-6580</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_6f78b5f3-90cc-46bd-b828-98e581849739">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_4a2e22ad-438d-49b4-a4d5-f0900fd38c43">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_13f79c29-8e15-4212-99d7-d1360d4ef519">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_0301cb99-79bf-4b9b-b576-e2b176ad45c7">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_f8ddab9f-4aa8-4fe0-92c6-6bcd16928f92">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_22ca2978-aebc-405f-874a-ba29fa85e53d">VOR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_339b2dcf-590f-4644-9ac5-762cb70315c7">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_28c011f0-7479-4f52-aeb4-b4e8f66e0985">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_bb4ba679-5702-494c-8228-5e49f4a42304"
      id="F_12c0cdeb-8d55-472a-8f04-58df855ddada">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
